Cancer Treatment Centers of America (CTCA) has made it their mission to partner up with NantHealth and Allscripts to enable eviti, a cancer software that allows health plans to provide oncologists with immediate pre-authorization for cancer treatment. Alongside eviti is the Clinical Pathways program, which helps provides treatment options to eliminate guessing from clinicians. CTCA’s Clinical Pathways platform alongside NantHealth’s eviti provides advanced cancer care to improve chemotherapy and ordering process, as well as CTCA’s ability to provide better care for each individual patient.
Established in 1988, by Richard T. Stephenson, who lost his mother to cancer, CTCA has been known to provide a combination of cancer treatments through various technologies and evidence-based support to aid each and every patient. For treatment, the use of surgery, chemotherapy, radiation, and immunotherapy are implemented to start cancer care, and therapy is provided to eliminate side effects such as pain, fatigue, nausea, anxiety, and depression. A team of oncologists are always on site to help patients decide on a treatment most suited for them. CTCA understands that all cancers aren’t made the same, so each individual is provided with their own unique care plan to help them reach their treatment goals.
CTCA has grown and developed through the use of state-of-the-art technologies that give precise care to each cancer patient. Old cancer treatments were created for the average cancer patient, excluding all those who were unique. Today, there’s a better understanding of how cancer forms and how to treat those with rare, hard to treat cancers. Experts use personalized treatments to ensure that every patient gets taken care of. CTCA is located in five major metropolitan cities across America: Atlanta, Georgia; Chicago, Illinois; Philadelphia, Pennsylvania; Phoenix, Arizona; and Tulsa, Oklahoma.